Antibody-mediated rejection induced cardiogenic shock: Too late for conventional therapy.

Guillaume CoutanceLucas Van AelstGuillaume HékimianCharles VidalPhilippe RouvierSamir SahebChantal GautreauPascal LeprinceShaida Varnous

Published in: Clinical transplantation (2018)

CS due to AMR occurred mostly in patients without history of AMR who developed de novo class II DSA. Despite aggressive conventional immunosuppressive therapies, prognosis after CS due to AMR was poor.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
diabetic rats
patient reported outcomes
mesenchymal stem cells
patient reported
stress induced